Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

Probability of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

Inflammation and hyperoxia decreases MBP expression. by Felix Brehmer (121526)

“…<p>A significantly decrease of MBP protein expression as a sign of hypomyelination occurs in all experimental settings with similar severity. …”

Rapamycin decreases Schwann cell markers, whereas statin induces Schwann cell markers. by Andrea Preitschopf (629851)

Fungal infection decreases cell proliferation. by Mariem Ben-Abdallah (181235)

Decreased mutagen susceptibility of WNV replication complex mutants. by Greta A. Van Slyke (761322)

MVK activates microglia and decreases phagocytosis. by Ren Y. Sato (16914027)

DJA2 decreases maturation of CFTR. by Patrick Kim Chiaw (7224539)

Neuroapoptosis decreases following CO exposure. by Ying Cheng (288456)

Expression of coilin decreases neurite outgrowth. by Benjamin Förthmann (498522)

“…For statistical evaluation, averaged relative neurite lengths of n>100 cells were compared, pooled from three individual experiments (means ± SEM; n.s.; A: **, p<0.01; Mann-Whitney test; B: n.s., non-significant; *, p<0.05; **, p<0.01; ***, p<0.001; Dunn’s test for comparison of multiple groups).…”

Expression and stability of EspA are decreased in the absence of <i>escA.</i> by Ching-Nan Lin (508587)

NRH treatment dose-dependently decreased the number of surviving HepG3 cells. by Manoj Sonavane (5340581)

IL-28A and IL-29 significantly decrease HCV replication. by Julia Diegelmann (107830)

Decreased neutrophil and monocyte antigen expression in the paws of anti-S100A9-treated mice. by Annabelle Cesaro (112070)

Posterior mean year-stage detection probabilities (red circles) and 95% Bayesian Credible Intervals (BCI; vertical black lines) of the (A) ≤100 m radius, and (B) infinite radius da... by Taza D. Schaming (8911517)

GSK3 inhibition results in a decrease of p-β-Catenin. by Germán Cuesto (701284)

“…Only the treatment with 2 and 10 μM of AR-A014418 decreased p-β-Catenin levels. The co-treatment with the PI3K activator did not induce a further reduction. …”

Decreased processivity of A3G NPM was attributable to changes in sliding, but not jumping movements. by Anjuman Ara (540372)

Overexpression of Tdp2 was associated with a decrease in HBV CCC DNA. by Xiuji Cui (755449)

Hcy decreased the level of H3K9me2 on the <i>COL1A1</i> promoter. by Wenjing Lei (772749)

CsA reduces Flk1 protein expression and significantly decreases the percentages of Flk1+ cells. by Seung-Cheol Choi (686982)

“…Scale bars = 100 μm. (C) Representative flow cytometry profiles showing the decreased percentages of Flk1+ cells in P19 cells treated with 0.32 μM CsA during EB formation for 48 and 96 h, respectively. …”